- Home
- BMRN vs ATR Comparison
BMRN vs ATR Comparison
Compare BMRN & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | ATR |
|---|---|---|
| Founded | 1996 | 1992 |
| Country | United States | United States |
| Employees | 3221 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 9.3B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BMRN | ATR |
|---|---|---|
| Price | $55.48 | $131.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 4 |
| Target Price | $88.22 | ★ $170.25 |
| AVG Volume (30 Days) | ★ 1.7M | 411.1K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ 6.51 |
| EPS | 1.80 | ★ 5.89 |
| Revenue | $1,313,646,000.00 | ★ $3,777,181,000.00 |
| Revenue This Year | $15.02 | $5.29 |
| Revenue Next Year | $12.23 | $4.98 |
| P/E Ratio | $30.52 | ★ $22.45 |
| Revenue Growth | ★ 17.62 | 5.42 |
| 52 Week Low | $50.76 | $103.23 |
| 52 Week High | $66.28 | $164.28 |
Technical Indicators
Market Signals| Indicator | BMRN | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 55.22 |
| Support Level | $51.77 | $129.06 |
| Resistance Level | $56.21 | $133.25 |
| Average True Range (ATR) | 1.36 | 2.99 |
| MACD | 0.08 | 1.12 |
| Stochastic Oscillator | 41.16 | 87.01 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.